Search Results

You are looking at 61 - 70 of 91 items for :

  • "hyperplasia" x
  • Refine by Access: All x
Clear All
Full access

Risk Reduction Strategies for Ductal Carcinoma In Situ

Adam L. Cohen and John H. Ward

the article or their competitors. References 1. Pinder SE Ellis IO . The diagnosis and management of pre-invasive breast disease: ductal carcinoma in situ (DCIS) and atypical ductal hyperplasia (ADH)—current definitions and

Full access

Principles of Surgical Management of Peritoneal Mesothelioma

Jessica A. Steadman and Travis E. Grotz

, biopsies, immunohistochemistry, discrimination between mesothelioma and reactive mesothelial hyperplasia, and biomarkers . J Clin Pathol 2013 ; 66 : 847 – 853 . 19. Grotz , Keith F . Fournier , Mann GN . Peritoneal malignancies . In: Feig BW

Full access

Principles of Treatment for Borderline, Micropapillary Serous, and Low-Grade Ovarian Cancer

Kari E. Hacker, Shitanshu Uppal, and Carolyn Johnston

proliferative, crowded glands and nuclear atypia. 26 These areas may resemble atypical endometrial hyperplasia or endometrioid carcinoma. They frequently arise in endometriotic cysts or are associated with either benign adenofibromas or endometrioid carcinomas

Full access

Role of Surgery for Locally Advanced and Metastatic Renal Cell Carcinoma

Robert Torrey, Philippe E. Spiess, Sumanta K. Pal, and David Josephson

false-positive nodes were enlarged because of inflammatory changes (especially in the presence of necrosis) or follicular hyperplasia. 23 Conversely, nodes that appeared negative on preoperative imaging or during intraoperative examination have been

Full access

Systematic Review of Randomized Controlled Trials of Exercise Interventions Using Digital Activity Trackers in Patients With Cancer

Kerry Schaffer, Narmadha Panneerselvam, Kah Poh Loh, Rachel Herrmann, Ian R. Kleckner, Richard Francis Dunne, Po-Ju Lin, Charles E. Heckler, Nicholas Gerbino, Lauren B. Bruckner, Eugene Storozynsky, Bonnie Ky, Andrea Baran, Supriya Gupta Mohile, Karen Michelle Mustian, and Chunkit Fung

hyperplasia and cancer . Gynecol Oncol 2016 ; 140 : 239 – 244 . 32. Marshall G . The Story of Fitbit: How a Wooden Box Became a $4 Billion Company . Available at: https

Full access

Evolving Roles of Histologic Evaluation and Molecular/Genomic Profiling in the Management of Endometrial Cancer

Rajmohan Murali, Deborah F. Delair, Sarah M. Bean, Nadeem R. Abu-Rustum, and Robert A. Soslow

2017 ; 67 : 7 – 30 . 2. Dijkhuizen FP Mol BW Brolmann HA Heintz AP . The accuracy of endometrial sampling in the diagnosis of patients with endometrial carcinoma and hyperplasia: a meta-analysis . Cancer 2000 ; 89 : 1765 – 1772 . 3

Full access

Understanding Causes of Inferior Outcomes in Adolescents and Young Adults With Cancer

Julie A. Wolfson, Kelly M. Kenzik, Blake Foxworthy, John M. Salsman, Katherine Donahue, Marie Nelson, Mary Beth Littrell, Grant R. Williams, and Jennifer M. Levine

features, Kamino bodies, epidermal hyperplasia), deeper lesions, and sentinel lymph node metastasis than expected among older adults with the same disease stage. CNS malignancies are seen across the age spectrum; gliomas represent the most common

Full access

Current Status of MRI and PET in the NCCN Guidelines for Prostate Cancer

Brandon R. Mason, James A. Eastham, Brian J. Davis, Lance A. Mynderse, Thomas J. Pugh, Richard J. Lee, and Joseph E. Ippolito

associated with benign prostatic hyperplasia, but apical peripheral zone lesions are missed more frequently. 34 – 36 In addition, smaller and less cellular lesions are less likely to be detected with mpMRI. 35 Next, radiologist interpretation may also pose

Full access

Adverse Effects of Androgen Deprivation Therapy: Defining the Problem and Promoting Health Among Men with Prostate Cancer

Philip J. Saylor and Matthew R. Smith

luteinizing hormone-releasing hormone agonist leuprolide on lipoproteins, fibrinogen and plasminogen activator inhibitor in patients with benign prostatic hyperplasia . J Urol 1995 ; 154 : 100 – 104 . 33. Lewington S Whitlock G

Full access

New Options for the Management of Castration-Resistant Prostate Cancer: A Case Perspective

Dawn Goetz

's medical history included hypercholesterolemia, hyperlipidemia, hypertension, and benign prostatic hyperplasia. Surgical History: The patient's surgical history included tonsillectomy at 15 years of age and prostatectomy in 2007. Social History: The